DNA methylation abnormalities in congenital heart disease

Epigenetics

Volumn 10, Issue 2, 2015, Pages 167-177

  Serra Juhé, Clara ^a,b,c   Cuscó, Ivon ^a,b,c   Homs, Aïda ^a,b,c   Flores, Raquel ^a,b,c   Torán, Núria ^b,d   Pérez Jurado, Luis A ^a,b,c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Congenital heart disease; DNA methylation; Down syndrome; Epimutation; Heart malformation

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR MSX1; DNA;

APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN SYNDROME; FEMALE; FETUS; FETUS HEART; FOLATE METABOLISM; GENE EXPRESSION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE CONTRACTION; MUTATION; PRINCIPAL COMPONENT ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ADULT; AGED; BLOOD; CONGENITAL HEART MALFORMATION; GENETIC ASSOCIATION; GENETICS; HEART MUSCLE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREGNANCY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DNA; DNA METHYLATION; FEMALE; FETUS; GENOME-WIDE ASSOCIATION STUDY; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PREGNANCY; YOUNG ADULT;

EID: 84924978077     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2014.998536     Document Type: Article

References (45)

1. Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13:679-92; PMID:22945394; http://dx.doi.org/10.1038/nrg3270
2. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011; 43:768-75; PMID:21706001; http://dx.doi.org/10.1038/ng.865
3. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004; 22:4632-42; PMID:15542813; http://dx.doi.org/10.1200/JCO.2004.07.151
4. Fradin D, Le Fur S, Mille C, Naoui N, Groves C, Zelenika D, McCarthy MI, Lathrop M, Bougneres P. Association of the CpG methylation pattern of the proximal insulin gene promoter with type 1 diabetes. PLoS One 2012; 7:e36278; PMID:22567146; http://dx.doi.org/10.1371/journal.pone.0036278
5. Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, Calonne E, Volkmar U, Igoillo-Esteve M, Naamane N, et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J 2012; 31:1405-26; PMID:22293752; http://dx.doi.org/10.1038/emboj.2011.503
6. Rao JS, Keleshian VL, Klein S, Rapoport SI. Epigenetic modifications in frontal cortex from Alzheimer’s disease and bipolar disorder patients. Transl Psychiatry 2012; 2:e132; PMID:22760556; http://dx.doi.org/10.1038/tp.2012.55
7. Connor CM, Akbarian S. DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics 2008; 3:55-8; PMID:18398310; http://dx.doi.org/10.4161/epi.3.2.5938
8. Abdolmaleky HM, Yaqubi S, Papageorgis P, Lambert AW, Ozturk S, Sivaraman V, Thiagalingam S. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr Res 2011; 129:183-90; PMID:21550210; http://dx.doi.org/10.1016/j.schres.2011.04.007
9. Kalter H, Warkany J. Medical progress. Congenital malformations: etiologic factors and their role in prevention (first of two parts). N Engl J Med 1983; 308:424-31; PMID:6337330; http://dx.doi.org/10.1056/NEJM198302243080804
10. Serra-Juhe C, Rodrıguez-Santiago B, Cusco I, Vendrell T, Camats N, Toran N, Perez-Jurado LA. Contribution of rare copy number variants to isolated human malformations. PLoS One 2012; 7:45530; PMID:23056206; http://dx.doi.org/10.1371/journal.pone.0045530
11. Soemedi R, Wilson IJ, Bentham J, Darlay R, Topf A, Zelenika D, Cosgrove C, Setchfield K, Thornborough C, Granados-Riveron J, et al. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet 2012; 91:489-501; PMID:22939634; http://dx.doi.org/10.1016/j.ajhg.2012.08.003
12. Hitz MP, Lemieux-Perreault LP, Marshall C, Feroz-Zada Y, Davies R, Yang SW, Lionel AC, D’Amours G, Lemyre E, Cullum R, et al. Rare copy number variants contribute to congenital left-sided heart disease. PLoS Genet 2012; 8:e1002903; PMID:22969434; http://dx.doi.org/10.1371/journal.pgen.1002903
13. Zaidi S, Choi M, Wakimoto H, Ma L, Jiang J, Overton JD, Romano-Adesman A, Bjornson RD, Breitbart RE, Brown KK, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 2013; 498:220-3; PMID:23665959; http://dx.doi.org/10.1038/nature12141
14. Weijerman ME, van Furth AM, van der Mooren MD, van Weissenbruch MM, Rammeloo L, Broers CJM, Gemke RJBJ. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr 2010; 169:1195-9; PMID:20411274; http://dx.doi.org/10.1007/s00431-010-1200-0
15. De Rubens Figueroa J, del Pozzo Magana B, Pablos Hach JL, Calderon Jimenez C, Castrejon Urbina R. Heart malformations in children with Down syndrome. Rev Esp Cardiol 2003; 56:894-9; PMID:14519277; http://dx.doi.org/10.1016/S0300-8932(03)76978-4
16. Locke AE, Dooley KJ, Tinker SW, Cheong SY, Feingold E, Allen EG, Freeman SB, Torfs CP, Cua CL, Epstein MP, et al. Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome. Genet Epidemiol 2010; 34:613-23; PMID:20718043; http://dx.doi.org/10.1002/gepi.20518
17. Yin M, Dong L, Zheng J, Zhang H, Liu J, Xu Z. Meta analysis of the association between MTHFR C677T polymorphism and the risk of congenital heart defects. Ann Hum Genet 2012; 76:9-16; PMID:22175539; http://dx.doi.org/10.1111/j.1469-1809.2011.00687.x
18. Bean LJH, Allen EG, Tinker SW, Hollis ND, Locke AE, Druschel C, Hobbs CA, Leary O, Romitti PA, Royle MH, et al. Lack of maternal folic acid supplementation is associated with heart defects in down syndrome: a report from the national Down syndrome project. Birth Defects Res A Clin Mol Teratol 2011; 91:885-93; PMID:21987466; http://dx.doi.org/10.1002/bdra.22848
19. Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, Klotzle B, Bibikova M, Fan JB, Gao Y, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 2013; 49:359-67; PMID:23177740; http://dx.doi.org/10.1016/j.molcel.2012.10.016
20. Blair JD, Price EM. Illuminating potential technical artifacts of DNA-methylation array probes. Am J Hum Genet 2012; 91:760-2; PMID:23040498; http://dx.doi.org/10.1016/j.ajhg.2012.05.028
21. Karpf AR. Epigenomic reactivation screening to identify genes silenced by DNA hypermethylation in human cancer. Curr Opin Mol Ther 2007; 9:231-41; PMID:17608021
22. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005; 2 1:S4-11; PMID:16341240; http://dx.doi.org/10.1038/ncponc0354
23. Shenker N, Flanagan JM. Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research. Br J Cancer 2012; 106:248-53; PMID:22166804; http://dx.doi.org/10.1038/bjc.2011.550
24. Rojas A, Kong SW, Agarwal P, Gilliss B, Pu WT, Black BL. GATA4 is a direct transcriptional activator of cyclin D2 and cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol Cell Biol 2008; 28:5420-31; PMID:18591257; http://dx.doi.org/10.1128/MCB.00717-08
25. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003; 424:443-7; PMID:12845333; http://dx.doi.org/10.1038/nature01827
26. Pehlivan T, Pober BR, Brueckner M, Garrett S, Slaugh R, Van Rheeden R, Wilson DB, Watson MS, Hing AV. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am J Med Genet 1999; 83 (3):201-6; PMID:10096597; http://dx.doi.org/10.1002/(SICI)1096-8628(19990319)83:3%3c201::AID-AJMG11%3e3.0.CO;2-V
27. Joyce JM, Fiedler SD, Brawner SJ, Liu H-Y, Zhou XG, Yu S. Cardiac defects are infrequent findings in individuals with 8p23.1 genomic duplications containing GATA4. Circ Cardiovasc Genet 2011; 4:620-5; PMID:21933911; http://dx.doi.org/10.1161/CIRCGENETICS.111.960302
28. Feng Y, Zhao L-Z, Hong L, Shan C, Shi W, Cai W. Alteration in methylation pattern of GATA-4 promoter region in vitamin a-deficient offspring’s heart. J Nutr Biochem 2013; 24:1373-80; PMID:23333085; http://dx.doi.org/10.1016/j.jnutbio.2012.11.005
29. Hill RE, Jones PF, Rees AR, Sime CM, Justice MJ, Copeland NG, Jenkins NA, Graham E, Davidson DR. A new family of mouse homeo box-containing genes: molecular structure, chromosomal location, and developmental expression of hox-7.1. Genes Dev 1989; 3:26-37; PMID:2565278; http://dx.doi.org/10.1101/gad.3.1.26
30. Robert B, Sassoon D, Jacq B, Gehring W, Buckingham M. Hox-7, a mouse homeobox gene with a novel pattern of expression during embryogenesis. EMBO J 1989; 8:91-100; PMID:2565810
31. Wieczorek D, Krause M, Majewski F, Albrecht B, Horn D, Riess O, Gillessen-Kaesbach G. Effect of the size of the deletion and clinical manifestation in wolfhirschhorn syndrome: analysis of 13 patients with a de novo deletion. Eur J Hum Genet 2000; 8:519-26; PMID:10909852; http://dx.doi.org/10.1038/sj.ejhg.5200498
32. Zollino M, Di Stefano C, Zampino G, Mastroiacovo P, Wright TJ, Sorge G, Selicorni A, Tenconi R, Zappala A, Battaglia A, et al. Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome. Am J Med Genet 2000; 94:254-61; PMID:10995514; http://dx.doi.org/10.1002/1096-8628(20000918)94:3%3c254::AID-AJMG13%3e3.0.CO;2-7
33. Chen Y-H, Ishii M, Sun J, Sucov HM, Maxson RE. Msx1 and Msx2 regulate survival of secondary heart field precursors and post-migratory proliferation of cardiac neural crest in the outflow tract. Dev Biol 2007; 308:421-37; PMID:17601530; http://dx.doi.org/10.1016/j.ydbio.2007.05.037
34. Chen Y-H, Ishii M, Sucov HM, Maxson RE. Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium. BMC Dev Biol 2008; 8:75; PMID:18667074; http://dx.doi.org/10.1186/1471-213X-8-75
35. Cordell HJ, Bentham J, Topf A, Zelenika D, Heath S, Mamasoula C, Cosgrove C, Blue G, Granados-Riveron J, Setchfield K, et al. Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nat Genet 2013; 45:822-4; PMID:23708191; http://dx.doi.org/10.1038/ng.2637
36. Lee H, Habas R, Abate-Shen C. MSX1 cooperates with histone H1b for inhibition of transcription and myogenesis. Science 2004; 304:1675-8; PMID:15192231; http://dx.doi.org/10.1126/science.1098096
37. Junker R, Kotthoff S, Vielhaber H, Halimeh S, Kosch A, Koch HG, Kassenbohmer R, Heineking B, Nowak-Gottl U. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 2001; 51:251-4; PMID:11470464; http://dx.doi.org/10.1016/S0008-6363(01)00286-3
38. Van Beynum IM, Kapusta L, den Heijer M, Vermeulen SHHM, Kouwenberg M, Daniels O, Blom HJ. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006; 27:981-7; PMID:16524890
39. Chang Z, Zhang Q, Feng Q, Xu J, Teng T, Luan Q, Shan C, Hu Y, Hemmings BA, Gao X, et al. Deletion of akt1 causes heart defects and abnormal cardiomyocyte proliferation. Dev Biol 2010; 347:384-91; PMID:20816796; http://dx.doi.org/10.1016/j.ydbio.2010.08.033
40. Rochais F, Dandonneau M, Mesbah K, Jarry T, Mattei M-G, Kelly RG. Hes1 is expressed in the second heart field and is required for outflow tract development. PLoS One 2009; 4:e6267; PMID:19609448; http://dx.doi.org/10.1371/journal.pone.0006267
41. Wang J, Nagy A, Larsson J, Dudas M, Sucov HM, Kaartinen V. Defective ALK5 signaling in the neural crest leads to increased postmigratory neural crest cell apoptosis and severe outflow tract defects. BMC Dev Biol 2006; 6:51; PMID:17078885; http://dx.doi.org/10.1186/1471-213X-6-51
42. Van den Berg G, Abu-Issa R, de Boer BA, Hutson MR, de Boer PAJ, Soufan AT, Ruijter JM, Kirby ML, van den Hoff MJB, Moorman AFM. A caudal proliferating growth center contributes to both poles of the forming heart tube. Circ Res 2009; 104:179-88; PMID:19059840; http://dx.doi.org/10.1161/CIRCRESAHA.108.185843
43. El-Maarri O, Becker T, Junen J, Manzoor SS, Diaz-Lacava A, Schwaab R, Wienker T, Oldenburg J. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum Genet 2007; 122:505-14; PMID:17851693; http://dx.doi.org/10.1007/s00439-007-0430-3
44. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009; 5: e1000602; PMID:19680444
45. Kamburov A, Wierling C, Lehrach H, Herwig R. ConsensusPathDB–a database for integrating human functional interaction networks. Nucleic Acids Res 2009; 37:D623-8; PMID:18940869; http://dx.doi.org/10.1093/nar/gkn698